Oppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $125.00) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

DexCom (DXCM) PT Raised to $170 at StephensNovember 7, 2018 8:34 AM DexCom (DXCM) PT Raised to $146 at BerenbergNovember 7, 2018 6:38 AM DexCom (DXCM) PT Raised to $157 at Piper JaffrayNovember 7, 2018 4:35 AM Form 10-Q DEXCOM INC For: Sep 30November 6, 2018 5:20 PM Form 8-K DEXCOM INC For: Nov 06November 6, 2018 4:05 PM DexCom (DXCM) Tops Q3 EPS by 27c, Revenues Beat; Lifts FY18 Revenue Outlook Above ConsensusNovember 6, 2018 4:02 PM